Cargando…
SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
Development of antibody protection during SARS-CoV-2 infection is a pressing question for public health and for vaccine development. We developed highly sensitive SARS-CoV-2-specific antibody and neutralization assays. SARS-CoV-2 Spike protein or Nucleocapsid protein specific IgG antibodies at titer...
Autores principales: | Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Gunter, Courtney, Yigit, Mesut, Hardy, Rachel, Plassmeyer, Matthew, Coatney, Paige, Lillard, Kimberleigh, Bukhari, Zaheer, Kleinberg, Michael, Hayes, Chelsea, Arditi, Moshe, Klapper, Ellen, Merin, Noah, Liang, Bruce Tsan-Tang, Gupta, Raavi, Alpan, Oral, Unutmaz, Derya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846565/ https://www.ncbi.nlm.nih.gov/pubmed/33514825 http://dx.doi.org/10.1038/s42003-021-01649-6 |
Ejemplares similares
-
Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE2
por: Dogan, Mikail, et al.
Publicado: (2022) -
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease
por: Limgala, Renuka Pudi, et al.
Publicado: (2016) -
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
por: Kroemer, Alexander, et al.
Publicado: (2020) -
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
por: Premeaux, Thomas A., et al.
Publicado: (2022) -
731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
por: Dailey, Joelynn, et al.
Publicado: (2021)